After heart or major blood vessel surgery, people with MS were less likely to go straight home than people without MS.
Researchers compared US hospital records for people with and without MS who had heart or major blood vessel surgery. After matching patients for a fairer comparison, deaths during the hospital stay were similar in both groups. About half of each group had at least one complication. Hospital stays and costs were also similar. Fewer people with MS went straight home after leaving the hospital.
This study looked at people with and without MS who had heart or major blood vessel surgery. The surgeries included procedures on the heart's arteries, valves, and the body's main artery. The findings concern what happened during the hospital stay and where patients went afterward. They may interest people with MS who want to understand how hospital outcomes compared with those of other patients. The study did not report results for specific forms of MS.
You should know this study used hospital records for 1,766,170 people, including 3,605 with MS. The researchers compared similar groups, but this was not a trial. The records do not show whether MS caused the difference in where people went after leaving the hospital.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More11/1/2026
Learn how brain support cells may affect inflammation in MS, why their roles can change, and what th
Read More11/1/2026
A study of 323 people with MS links blood chemicals to walking, thinking, and changes. Learn why the
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JAMA surgery often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.